Finance

Lists
603079:SHA
Zhejiang Shengda Bio-pharm Co Ltd
12,45 CN¥
+0,48%
(+0,060) 1D
16 қаз., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603079...
Open
12,46 CN¥
High
12,83 CN¥
Low
12,27 CN¥
Mkt. cap
2,35 млрд
Avg. vol.
5,75 млн
Volume
3,79 млн
Dividend
0,80%
Quarterly dividend
0,03 CN¥
Ex-dividend date
2026 ж. 01 шіл.
P/E ratio
51,57
52-wk high
22,00 CN¥
52-wk low
9,94 CN¥
EPS
0,24 CN¥
Shares outstanding
112,00 млн
No. of employees
1 мың
Open
12,46 CN¥
High
12,83 CN¥
Low
12,27 CN¥
Mkt. cap
2,35 млрд
Avg. vol.
5,75 млн
Volume
3,79 млн
Dividend
0,80%
Quarterly dividend
0,03 CN¥
Ex-dividend date
2026 ж. 01 шіл.
P/E ratio
51,57
52-wk high
22,00 CN¥
52-wk low
9,94 CN¥
EPS
0,24 CN¥
Shares outstanding
112,00 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Zhejiang Shengda Bio-pharm Co Ltd
CEO-
Employees1,08 мың
Founded1999 ж. 08 ақп.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. мау.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
197,50 млн
223,25 млн
189,22 млн
199,84 млн
Cost of goods sold
145,85 млн
175,36 млн
136,99 млн
144,97 млн
Cost of revenue
145,85 млн
175,36 млн
136,99 млн
144,97 млн
Research and development expenses
12,85 млн
18,11 млн
10,09 млн
13,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,54 млн
22,59 млн
20,29 млн
21,99 млн
Operating expense
33,73 млн
48,77 млн
31,77 млн
39,22 млн
Total operating expenses
179,59 млн
224,13 млн
168,75 млн
184,19 млн
Operating income
17,92 млн
-879,22 м.
20,46 млн
15,65 млн
Other non operating income
-503,85 м.
283,41 м.
-3,83 млн
3,63 млн
EBT including unusual items
22,53 млн
8,03 млн
18,58 млн
13,30 млн
EBT excluding unusual items
19,23 млн
-279,90 м.
19,37 млн
13,02 млн
Income tax expense
5,45 млн
-2,51 млн
3,27 млн
4,09 млн
Effective tax rate
24,20%
-31,26%
17,59%
30,77%
Other operating expenses
1,31 млн
7,99 млн
1,54 млн
3,51 млн
Net income
16,10 млн
8,82 млн
13,17 млн
7,35 млн
Net profit margin
8,15%
3,95%
6,96%
3,68%
Earnings per share
-
-
-
-
Interest and investment income
1,24 млн
2,80 млн
2,86 млн
3,33 млн
Interest expense
-178,48 м.
-45,11 мың
-115,42 м.
-1,93 млн
Net interest expenses
1,06 млн
2,75 млн
2,74 млн
1,40 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
35,88 млн
17,98 млн
39,32 млн
36,53 млн
Gain or loss from assets sale
86,18 мың
477,31 м.
-
563,49 м.
AI content may include mistakes. Learn more
Google қолданбалары